Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Pharm Res. 2019 Sep 16;36(11):161. doi: 10.1007/s11095-019-2691-7

Fig. 7.

Fig. 7

ApoE expression in C57BL/6 mice treated with liposomal formulations containing plasmid ApoE2 after 5 days of liposome administration. ApoE levels were quantified in different organs (brain, liver, kidneys, heart, lungs, spleen and blood) harvested from mice treated with plasmid ApoE2, Plain-liposome and Tf-Pen-liposomes containing chitosan-pApoE2 complexes (1 mg pDNA/kg body weight). Seven mice were used per group. Data are expressed as mean ± SD. Statistically significant differences (p < 0.05) are shown as (*).